Antibodies Against Equine ALG During Treatment of Rejection Crisis after Renal Allotransplantation
- 29 June 1975
- journal article
- clinical trial
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 4 (4) , 369-372
- https://doi.org/10.1111/j.1365-3083.1975.tb02638.x
Abstract
The development of antibodies to equine anti-human-lymphocyte globulin (ALG) was followed using passive hemagglutination and gel diffusion, and to Forssman antigen using direct sheep erythrocyte agglutination, in a controlled clinical investigation of ALG treatment of established rejection of renal allografts in a total of 12 patients. With passive hemagglutination a weak antibody to ALG was seen only in one case. There was no increase in titer for sheep erythrocyte antigens during treatment, which agrees well with clinical observations in which no anaphylactic reactions were seen.Keywords
This publication has 4 references indexed in Scilit:
- A Controlled Clinical Trial of Treatment with ALG in Established Rejection of Renal AllograftsActa Medica Scandinavica, 1975
- Antibody Formation to Equine Anti-Lymphocytic Globulin (ALG) in Man: Effect on Absorption, Distribution and Effectiveness of the ALGThe Journal of Immunology, 1971
- Serologische Untersuchungen an Patienten unter Behandlung mit xenogenem AntilymphocytenglobulinKlinische Wochenschrift, 1970
- Clinical Reactions and Serologic Changes After the Administration of Heterologous Antilymphocyte Globulin to Human Recipients of Renal HomograftsAnnals of Internal Medicine, 1968